Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, if he will publish an update on the UK’s covid-19 vaccine portfolio, including the number of doses secured with each manufacturer.
The UK Government has secured early access to 407 million vaccines doses through supply agreements with seven separate vaccine developers. This includes agreements with:
In addition, we announced a non-binding agreement in February 2021 with CureVac for 50 million doses and have a reservation agreement with GlaxoSmithKline and Sanofi Pasteur for 60 million doses.